Nicholas Investment Partners, LP Adma Biologics, Inc. Transaction History
Nicholas Investment Partners, LP
- $912 Million
- Q4 2024
A detailed history of Nicholas Investment Partners, LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 177,382 shares of ADMA stock, worth $3.78 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
177,382
Previous 283,696
37.47%
Holding current value
$3.78 Million
Previous $5.67 Million
46.36%
% of portfolio
0.33%
Previous 0.63%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
346Shares Held
181MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$397 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$388 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$317 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$241 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$118 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.18B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...